Results 231 to 240 of about 434,321 (269)
Some of the next articles are maybe not open access.
Journal of Leukocyte Biology, 1999
Abstract There is considerable but as yet incomplete evidence for two developmental lineages of dendritic cells: a myeloid lineage shared with phagocytes and a lymphoid lineage shared with T cells. The two corresponding functional states, which may not require the existence of two formal lineages, are that myeloid dendritic cells capture
R M, Steinman, K, Inaba
openaire +2 more sources
Abstract There is considerable but as yet incomplete evidence for two developmental lineages of dendritic cells: a myeloid lineage shared with phagocytes and a lymphoid lineage shared with T cells. The two corresponding functional states, which may not require the existence of two formal lineages, are that myeloid dendritic cells capture
R M, Steinman, K, Inaba
openaire +2 more sources
The Lancet, 2006
Acute myeloid leukaemia (AML) is a heterogeneous clonal disorder of haemopoietic progenitor cells and the most common malignant myeloid disorder in adults. The median age at presentation for patients with AML is 70 years. In the past few years, research in molecular biology has been instrumental in deciphering the pathogenesis of the disease.
Elihu, Estey, Hartmut, Döhner
openaire +2 more sources
Acute myeloid leukaemia (AML) is a heterogeneous clonal disorder of haemopoietic progenitor cells and the most common malignant myeloid disorder in adults. The median age at presentation for patients with AML is 70 years. In the past few years, research in molecular biology has been instrumental in deciphering the pathogenesis of the disease.
Elihu, Estey, Hartmut, Döhner
openaire +2 more sources
Orbit, 2016
Re: Grigalunas AL, Mizen TR. Myeloid sarcoma of the orbit without systemic recurrence of disease in an adult: A clinicopathological case report.
Kamal Kant, Sahu +2 more
openaire +2 more sources
Re: Grigalunas AL, Mizen TR. Myeloid sarcoma of the orbit without systemic recurrence of disease in an adult: A clinicopathological case report.
Kamal Kant, Sahu +2 more
openaire +2 more sources
Mutations in Myeloid Neoplasms
Diagnostic Molecular Pathology, 2008The introduction of molecular techniques in the study of myeloid neoplasms has resulted in the identification of numerous genetic abnormalities with diagnostic and prognostic significance. The impact of these recent discoveries cannot be understated, as the definitions of several myeloid neoplasms have been changed to include new, molecular criteria ...
Claudiu V, Cotta, Raymond R, Tubbs
openaire +2 more sources
Hematology, 2003
AbstractChronic myeloid leukemia (CML) was the first human malignancy to be associated with a specific genetic lesion, the Philadelphia chromosome, harboring the BCR-ABL oncogene. Since then, it has become a paradigm for the discovery of molecular mechanisms and targeted therapeutic approaches in the field of hematologic neoplasias. The past 5 years or
Junia V, Melo +2 more
openaire +2 more sources
AbstractChronic myeloid leukemia (CML) was the first human malignancy to be associated with a specific genetic lesion, the Philadelphia chromosome, harboring the BCR-ABL oncogene. Since then, it has become a paradigm for the discovery of molecular mechanisms and targeted therapeutic approaches in the field of hematologic neoplasias. The past 5 years or
Junia V, Melo +2 more
openaire +2 more sources
New England Journal of Medicine, 1999
Löwenberg, Bob, Downing, JR, Burnett, A
openaire +3 more sources
Löwenberg, Bob, Downing, JR, Burnett, A
openaire +3 more sources
Epigenetics in Myeloid Malignancies
2012Myeloid hematological malignancies are among the epigenetically best characterized neoplasms. The comparatively low number of recurring balanced and unbalanced chromosomal abnormalities as well as common genetic mutations has enabled scientists to relate epigenetic states to these.
openaire +2 more sources
Whole-genome sequencing for myeloid disease: one assay to stratify them all?
Nature Reviews Clinical Oncology, 2021John Byrd
exaly
Treatment-free remission in patients with chronic myeloid leukaemia
Nature Reviews Clinical Oncology, 2020David Ross +2 more
exaly